T2DM Therapeutics Flashcards

(68 cards)

1
Q

Choice if someone has HF

A

sglt2 —- evidence of 2nd prevention (not primary)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug of choice if someone has CKD

A

sglt2i or GLP-1a
—- both 2nd prevention; cardio renal protective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drug of choice if someone has CVD

A

sglt2i or GLp-1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T or F: if someone is a new T2DM w eGFR < 30 , its okay to start on metformin

A

F- avoid starting if eGFR < 30

fully CI if eGFR < 15

dose adjust once less than 45 (MDD 1000mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metformin A1c lowering abilities

A

1-1.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When it metformin CI

A

severe renal or liver dysfunction, severe infection or dehydration, CV collapse, previous lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SEs of metformin

A

GI, metallic taste + lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metformins impact on weight

A

neutral + low hypo risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What vitamin can metformin impact the absorption of

A

B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should all be monitored when on metformin

A

A1c, SCr, Hg, and B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Brand names of metformin

A

glucophage — IR
glumetza ER (may helps with Ses; take with evening meal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is lactic acidosis

A

elevation of blood lactate < 5, decreased pH, electrolyte disturbances w/ increased anion gap

—- normally happens when on metformin ++++ respiratory failure or renal insuffiency
—- accumulation of metformin ; decrease conversion of lactate to glucose — increased lactate production

** don’t know if metformin is cause or just associated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs are the best options for weight loss

A

semaglutide (injection) or tirzepatide

other high; dulaglutide + liraglutide

mid: SGLT2, exenatide, lixisenatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which drugs have the highest hypo risk

A

premixed insulin, glinide, SU, basal insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Best A1C lowers w/ metformin

A

premixed insulin ; GLP-1a (lower by around 1)

mid: SGLT2, SU, TZDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which of the SGLT2i have to be dosed before 1st meal of the day

A

Canagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SEs of SGLT2i

A

volume depletion, GU infections (3-4X more likely), DKA (2X), thirst, need to pee more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T or F: don’t start an sglt2 if eFGR is less than 20

A

T- if already on, can leave on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which sglt2i has an increased risk of amputations or fracture

A

cana

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

T or F: SGLT2i provide 2nd prevention for CKD, HF, and CVD

A

T- not primary
— only studied to show benefit in those who already have these conditions + preventing progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What to monitor when on SGLT2i

A

Renal fxn, volume, A1c, DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MoA of SGLT2

A

reduce glucose reabsorption in PCT
- in T2DM: lower renal threshold for when we stop reabsorbing glucose by 4-5 mmol/L (normally stop reabsorbing at 10)
—- this counteracts this and helps us “return to normal” and stop reabsorbing glucose at normal level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Is if normal for SGLT2i to cause an initial decline in renal fxn

A

yes - decrease by 4-6 mL/min
—- if decreases by more than 15-20% ; stop or decrease dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which GLP-1a injection is given daily

A

liraglutide - daily injection
semaglutide + dulaglutide - weekly (D has to be at the same time)

  • rybelsus: daily PO option (taken first thing in the am with water)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
When is GLP-1a CI
thyroid medullary cancer or MENS
26
T or F: SA GLP-1a have more SEs than LA
T
27
T or F: we don’t know whether or not rybelsus provides the same CV protection as the other GLP-1a
F- SOUL study showed it does help reduce risk of MACE
28
What is tirzepatide ?
GLP-1a + GIP — no CVD evidence yet but does show to be better at weight loss + lowering A1c than ozempic
29
Ozempic dosing
0.25mg SC weekly x 4 wk; increase to 0.5 ; max of 1 Rybelusus: 7-14mg once daily
30
What DPP-4 should we avoid in HF
saxagliptin (Savor time 53 study)
31
which DPP-4 doesn’t have to be renally dose adjusted
lingaliptin
32
T or F: DPP4s help improve PP glucose control
T- helps increase duration of our natural GLP-1 by preventing its breakdown —— all its fxn comes down to our body’s normal release of GLP-1 in response to glucose
33
T or F: DPP4 has some evidence of 2nd CV protection
F- CV neutral
34
T or F: DDP4i only help improve insulin release while GLP-1a help with that + delaying gastric emptying, decreasing appetite
T — DPP4 are less potent
35
SEs of DPP4s
headache and nasopharygnitis - no impact on weight or hypo risk
36
What TzD is still on the market
pioglitazone 15-45 mg once daily - must be taken at same time daily
37
SEs of TZDs
edema, HF (new and worsening) , weight gain R—- MI P— bladder cancer women— fractures CI if HF or RF for HF
38
What are one positives of Tzds
allow for longer duration of glycemic control —negative take 6-12 wks for max effect
39
WHen might TZds we used
post stroke or if someone has severe insulin R
40
What is repaglinide
Meglitinide —- must be dosed with each meal (16mg MDD) - skip if don’t have meal - stimulates insulin release
41
Ses of Meglitinides
hypo, weight gain, headache - less hypo risk than SU —- little impact on A1C — short duration + rapid onset
42
What are the 2nd gen SUs
Glyburide (safe in preg), gliclazide (normal + MR) and glimepiride
43
SEs of SUs
hypo risk (highest with glyburide, lowest with gliclazide) 1st gen: increase risk of CV mortality — mid A1c lowering: decrease efficacy overtime
44
T or F: you should decrease your dose of SUs if old or have CKD
T
45
What is acarbose
alpha-glucosidase inhibitor — must be taken with first bite of food - avoid if GI disorder — weight neutral + low hypo risk
46
Does acarbose have a benefit on CV health
no - neutral
47
T or F: if hypo and on acarbose, you should treat with glucagon
F- dextrose of glucose (simple sugars)
48
When do we start T2DM on insulin
- not meeting glycemic targets - metabolic decompensation (DKA ex//)
49
How do we start T2DM on insulin
1) start with basal - 10 units at HS (increase 1 unit daily until reach target if glargine; degludec — increase by 4 units a week/ 2 units every 3-4 days)
50
How do we know what to insulin dose to start a T2DM that is less than 50kg on
use 0.1-0.2 units/kg
51
When do we normal stop oral meds such as SUs when getting a T2DM started on insulin
normally once start them on bolus —- bolus with largest meal (10% of basal or 4 units)
52
Which insulin has less hypo risk in T2DM: degludec or glargine
degludec — less nocturnal, severe, symptomatic when comparing to U100 glargine
53
Differences bw glargine U100 and U300 in T2DM
U300- less overall hypo, nocturnal and symptomatic hypo than U100
54
T or F: there is a difference in the weight gain seen bw the different basal insulins
F
55
Insulin icodec starting dose: T2DM never been on insulin
70 units weekly
56
Insulin icodec dosing: T2DM on previous insulin
LD: 1.5 x basal x 7 days MD: basal x7 days
57
Insulin Icodec dosing T1DM
A1c>/=8 - LD: 2 x basal x7 days MD: basal x 7days A1c< 8 on glargine U300 or BID basal - LD: 1.5 x basal x 7 MD: basal x7
58
T or F: we have seen an increase in severe hypo in those on insulin icodec in comparison to the other basal insulins
T - increase in T1DM
59
Is insulin icodec better at lowering A1c than other basal insulins
yes - works just as good, if not better
60
what is the A1c target for most T1DM and T2DM
61
What is the A1c target of someone with a frailty index of 4-5
7.1-8% - functionally dependent
62
A1c target with frailty index of 6-8
7.1-8.5
63
Do we use A1c to monitor efficacy in end of life
no
64
What is the best way to measure BG
fingertip — senses more rapid changes — use if think hypo, following exercise or insulin admin alternative: palm, forearm, thigh (less BF + slower changes)
65
What do CGM measure
BG in interstitial fluid (slight delay)
66
What is fructosamine and how does it work
way to measure BG - reflects average BG control over last 2-3 wks ( based on a non-enzymatic glycation of serum proteins such as albumin) - not covered only use if A1c not reliable (blood loss) + for ST glucose monitoring
67
IF A1c is super high, what bg reading should we focus on controlling
FPG — once closer to 7 —. focus on PPG control (this has a larger impact on A1c now)
68
What are the ergregious eleven
1) decrease B cell fxn or mass 2) decrease incretin effect 3) alpha cell defect: unusual glucagon release 4) adipose: decrease insulin S 5) Muscle : decrease S 6) Liver: increase insulin R 7) Brain: 8) colon: increased gastric emptying 9) Immune dysregulation 10) Stomach or SI 11) kidney: increase glucose reabsorption